SomnoSnore

Press Release

SCDL are excited to release the latest clinically proven anti-snoring device known as SomnoSnore. This state of the art mandibular advancement concept designed for the primary snoring patient only, is unique in that 3 splints are  fabricated for each patient at pre-established protrusive measurements. The maxillary device is coupled with the first mandibular counterpart at 50% of the maximum protruded capability. If the device diminishes in efficacy, the second mandibular device is inserted at a further 2mm of protrusion. For optimum comfort, every anti snoring system is fabricated using a unique 'memory fit' material. The devices are designed and fabricated by the Sydney based company SomnoMed (ASX:SOM) which has an excellent clinically proven record in oral appliance therapy. At $249, this product represents a quality, clinically proven, value for money solution for every primary snoring patient. A 30 night money back guarantee is provided for each device.

PVS impressions of both arches are required, in tandem with a protrusive bite registration.

SomnoSnore is a 3-step system which includes;

• 1 upper splint

• 1 initial advancement splint at 50% protrusion

• 1 forward advancement splint at 50% protrusion + 2mm

Download Flyers & Patient Consent Form

Please click on the image below to download.